iRhythm Technologies is a medical devices business based in the US. iRhythm Technologies shares (IRTC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $73.74 – a decrease of 15.37% over the previous week. iRhythm Technologies employs 2,000 staff and has a trailing 12-month revenue of around $560 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $73.74 |
|---|---|
| 52-week range | $55.92 - $124.12 |
| 50-day moving average | $72.02 |
| 200-day moving average | $92.35 |
| Wall St. target price | $98.27 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-4.85 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $76.86 from 2024-11-18
| 1 week (2024-11-13) | -11.79% |
|---|---|
| 1 month (2024-10-18) | 22.64% |
| 3 months (2024-08-20) | 9.91% |
| 6 months (2024-05-20) | -17.01% |
| 1 year (2023-11-20) | -8.05% |
|---|---|
| 2 years (2022-11-18) | -27.91% |
| 3 years (2021-11-19) | 100.25 |
| 5 years (2019-11-20) | 8.21% |
| Revenue TTM | $560 million |
|---|---|
| Gross profit TTM | $281.6 million |
| Return on assets TTM | -8.93% |
| Return on equity TTM | -103.34% |
| Profit margin | -26.9% |
| Book value | $2.29 |
| Market Capitalization | $2.6 billion |
TTM: trailing 12 months
We're not expecting iRhythm Technologies to pay a dividend over the next 12 months.
Over the last 12 months, iRhythm Technologies's shares have ranged in value from as little as $55.92 up to $124.115. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while iRhythm Technologies's is 1.229. This would suggest that iRhythm Technologies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
iRhythm Technologies, Inc. , a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California. .
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.